EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study

Nasim Rezaee, Eugene Hone, Hamid Sohrabi, Rasheed Abdulraheem, Stuart K Johnson, Stuart Gunzburg, Ralph N Martins, W M A D Binosha Fernando

Nutrients · 2025-01-30 · 17 (3) · 516

DOI: 10.3390/nu17030516 ↗

At a glance

Journal article in Nutrients, published on 2025-01-30. Written by Nasim Rezaee and 7 co-authors. Institution: Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Aust…. Major MEDLINE topics: tau Proteins, Alzheimer Disease, Mitochondria, Sorghum. Cited 6 times so far (Crossref); 87 references. The full text is freely available (open access, CC BY 4.0). Funded by: Edith Cowan University and Cwek Pty Limited.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with poorly understood pathology. Elevated tau, phospho-tau and mitochondrial dysfunction are significantly correlated with an increased risk of AD and are therefore targets for disease-modifying therapy. In this study, we examined the effects of polyphenolic extracts from six different varieties of sorghum: Shawaya short black-1 (Black), IS1311C (Brown), QL33/QL36 (Red), B923296 (Red), QL12 (White), and QL33 (Red) on the attenuation of beta amyloid-induced phospho-tau levels, total tau levels, and mitochondrial dysfunction in neuronal cells.

Method

Tau proteins (231 (pT231), Serine- 199 (pS199), and total tau proteins (T-tau)) were detected and quantified using sandwich ELISA kits, while mitochondrial dysfunction was measured in terms of mitochondrial membrane potential (Δψm) and adenosine triphosphate (ATP) levels.

Results

Almost all varieties of the sorghum extracts reduced the beta amyloid-induced pS199 and pT231 levels (p ≤ 0.05). The optimum concentration of QL33/QL36 (1000 µg/mL), QL12 (2000 µg/mL), and QL33 (2000 µg/mL) strongly attenuated the phospho-tau level. Sorghum IS1311C (750 µg/mL) showed the highest Δψm reduction (39.8%), whereas QL33 (2000 µg/mL) most strongly improved the ATP level (37.7%) (p ≤ 0.01). For both Δψm and ATP assays, the least activity was observed in sorghum B923296 at 21% and 25.5%, respectively (p ≤ 0.01).

Conclusions

The polyphenol extracts from sorghum attenuated the tau toxicity and Aβ-induced mitochondrial dysfunction in a variety- and dose-dependent manner and made a promising disease-modifying agent against AD. However, extensive research is needed to validate the efficacy of the sorghum extracts prior to animal and clinical studies.

Subjects

MeSH terms (MEDLINE)

tau ProteinsAlzheimer DiseaseMitochondriaSorghumPlant ExtractsPolyphenolsIn Vitro TechniquesHumansPhosphorylationDose-Response Relationship, DrugAdenosine TriphosphateMembrane Potential, MitochondrialAmyloid beta-PeptidesNeurons

Author keywords

Alzheimer’s diseaseamyloid beta proteinhuman taumitochondriapolyphenolssorghum

Substances

tau ProteinsPlant ExtractsPolyphenolsAdenosine TriphosphateAmyloid beta-Peptides

Authors and institutions

  • Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia.
  • Centre for Ageing, Health Future Institute, Murdoch University, Murdoch, WA 6150, Australia.
  • Department of Biomedical Sciences, Macquarie University, Sydney, NSW 2109, Australia.
  • IngredientsbyDesign Pty Ltd., Lesmurdie, WA 6076, Australia.
  • CWEK Pty Ltd., South Fremantle, WA 6162, Australia.

Funding

  • Edith Cowan University and Cwek Pty Limited

Cite

APA

Rezaee, N., Hone, E., Sohrabi, H., Abdulraheem, R., Johnson, S. K., Gunzburg, S., Martins, R. N., & Fernando, W. M. A. D. B. (2025). Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study. Nutrients. https://doi.org/10.3390/nu17030516

Vancouver

Rezaee N, Hone E, Sohrabi H, Abdulraheem R, Johnson SK, Gunzburg S, et al. Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study. Nutrients. 2025. doi:10.3390/nu17030516

BibTeX
@article{Rezaee2025,
  author = {Rezaee, Nasim and Hone, Eugene and Sohrabi, Hamid and Abdulraheem, Rasheed and Johnson, Stuart K and Gunzburg, Stuart and Martins, Ralph N and Fernando, W M A D Binosha},
  title = {Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17030516}
}
Start for free →